Breast Cancers
GI Cancers
Gynecologic Cancer
Immunology News
Head & Neck
Lung Cancers
Prostate Cancer
Precision Medicine

Latest News & Updates

Latest Articles
The Nobel Prize winning director of the National Cancer Institute, Harold Varmus, MD, has tendered his resignation in a letter to President Barack Obama, citing economic restraints as a leading cause for his departure.
A nearly $1 billion windfall licensing agreement involving the immunotherapy PROSTVAC has the company Bavarian Nordic looking toward a long-term manufacturing and distribution arrangement with Bristol-Myers Squibb.
Acting 3 months ahead of schedule, the FDA approved nivolumab (Odivo) for patients with squamous non-small cell lung cancer.
Emmanuel S. Antonarakis, MBBCh, discusses research examining AR-V7 as a biomarker for chemotherapy efficacy in advanced prostate cancer.
The reduction of breast cancer risk with 5 years of tamoxifen does not outweigh the lack of a mortality benefit, according to J. Michael Dixon, MD, OBE, who shared his view in a session at the 32nd Annual Miami Breast Cancer Conference.
Latest Peer Exchange Discussions
Lecia Sequist, MD, Corey Langer, MD, and Mark Socinski, MD, describe the current and emerging strategies for treating acquired resistance to frontline tyrosine kinase inhibitors. View Now
In this segment, Anas Younes, MD, and John Sweetenham, MD, discuss treatment of relapsed and refractory Hodgkin lymphoma. View Now
In this segment, the panelists discuss RAS testing for patients with colorectal cancer. View Now
Arza Raza, MD, discusses the new oral iron chelation agents available to reduce iron overload in myelodysplastic syndrome. View Now
Online CME Activities
Free CME from PER
Recap of SABCS 2014: Changes for Today and Hope for Tomorrow
Cancer Summaries and Commentaries: Updates From San Francisco in Multiple Myeloma
10th International Symposium on Ovarian Cancer and Gynecologic Malignancies® Medical Crossfire®
Community Practice Connections: 12th Annual International Congress on Targeted Therapies in Cancer®